175 related articles for article (PubMed ID: 6608506)
1. Suppressed cellular immunity in mice harboring intraocular melanomas.
Niederkorn JY
Invest Ophthalmol Vis Sci; 1984 Apr; 25(4):447-54. PubMed ID: 6608506
[TBL] [Abstract][Full Text] [Related]
2. Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed-type hypersensitivity but normal cytotoxic T lymphocyte and helper T lymphocyte responses.
Niederkorn JY; Streilein JW
J Immunol; 1983 Dec; 131(6):2670-4. PubMed ID: 6196396
[TBL] [Abstract][Full Text] [Related]
3. A role for mast cells and the vasoactive amine serotonin in T cell-dependent immunity to tumors.
Van Loveren H; Den Otter W; Meade R; Terheggen PM; Askenase PW
J Immunol; 1985 Feb; 134(2):1292-9. PubMed ID: 3871209
[TBL] [Abstract][Full Text] [Related]
4. Intracamerally induced concomitant immunity: mice harboring progressively growing intraocular tumors are immune to spontaneous metastases and secondary tumor challenge.
Niederkorn JY; Streilein JW
J Immunol; 1983 Nov; 131(5):2587-94. PubMed ID: 6415174
[TBL] [Abstract][Full Text] [Related]
5. Direct in vitro evidence for different susceptibilities to 4-hydroperoxycyclophosphamide of antigen-primed T cells regulating humoral and cell-mediated immune responses to sheep erythrocytes: a possible explanation for the inverse action of cyclophosphamide on humoral and cell-mediated immune responses.
Diamantstein T; Klos M; Hahn H; Kaufmann SH
J Immunol; 1981 May; 126(5):1717-9. PubMed ID: 6452475
[TBL] [Abstract][Full Text] [Related]
6. Demonstration of intratumoral infiltration of tumor-specific Lyt-1+2- T cells mediating delayed-type hypersensitivity response and in vivo protective immunity.
Tomita S; Fujiwara H; Yamane Y; Sano S; Nakajima H; Izumi Y; Arai H; Kawanishi Y; Tsuchida T; Hamaoka T
Jpn J Cancer Res; 1986 Feb; 77(2):182-9. PubMed ID: 3082830
[TBL] [Abstract][Full Text] [Related]
7. Immunoregulation of intraocular tumours.
Niederkorn JY
Eye (Lond); 1997; 11 ( Pt 2)():249-54. PubMed ID: 9349421
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous immune rejection of intraocular tumors in mice.
Niederkorn JY; Meunier PC
Invest Ophthalmol Vis Sci; 1985 Jun; 26(6):877-84. PubMed ID: 3924853
[TBL] [Abstract][Full Text] [Related]
9. The mechanism of tolerance induction of tumor-specific delayed-type hypersensitivity responses by intravenous inoculation of tumor cells.
Sato S; Fukuzawa M; Nakajima H; Ogata M; Kosugi A; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1985 Nov; 76(11):1099-106. PubMed ID: 2935516
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the immune response. I. Suppression of delayed-type hypersensitivity by T cells from mice expressing humoral immunity.
Ramshaw IA; Bretscher PA; Parish CR
Eur J Immunol; 1976 Oct; 6(10):674-9. PubMed ID: 1087845
[TBL] [Abstract][Full Text] [Related]
11. Delayed-type hypersensitivity to sheep red blood cells in selected lines of mice with high or low antibody responses.
Lagrange PH; Michel JC; Hurtrel B; Thickstun PM
Ann Immunol (Paris); 1980; 131C(3):257-77. PubMed ID: 7406440
[TBL] [Abstract][Full Text] [Related]
12. Residual immunogenicity of irradiated spleen cell suspensions after a single intravenous injection of sheep red blood cells in mice.
Lagrange PH; Hurtrel B; Michel JC
Ann Immunol (Paris); 1980; 131D(2):137-51. PubMed ID: 6970541
[TBL] [Abstract][Full Text] [Related]
13. Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line.
Waanders GA; Rimoldi D; Liénard D; Carrel S; Lejeune F; Dietrich PY; Cerottini JC; Romero P
Clin Cancer Res; 1997 May; 3(5):685-96. PubMed ID: 9815737
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cell-mediated immunity in cryptococcosis. III. Characterization of second-order T suppressor cells (Ts2).
Murphy JW; Mosley RL
J Immunol; 1985 Jan; 134(1):577-84. PubMed ID: 3155471
[TBL] [Abstract][Full Text] [Related]
15. Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors.
Knisely TL; Luckenbach MW; Fischer BJ; Niederkorn JY
J Immunol; 1987 Jun; 138(12):4515-23. PubMed ID: 3108394
[TBL] [Abstract][Full Text] [Related]
16. Implication for the CD94/NKG2A-Qa-1 system in the generation and function of ocular-induced splenic CD8+ regulatory T cells.
Chattopadhyay S; O'Rourke J; Cone RE
Int Immunol; 2008 Apr; 20(4):509-16. PubMed ID: 18359787
[TBL] [Abstract][Full Text] [Related]
17. Enucleation in consort with immunologic impairment promotes metastasis of intraocular melanomas in mice.
Niederkorn JY
Invest Ophthalmol Vis Sci; 1984 Sep; 25(9):1080-6. PubMed ID: 6381375
[TBL] [Abstract][Full Text] [Related]
18. Immunohistological analysis of peptide-induced delayed-type hypersensitivity in advanced melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cell vaccination.
Nakai N; Katoh N; Germeraad WT; Kishida T; Ueda E; Takenaka H; Mazda O; Kishimoto S
J Dermatol Sci; 2009 Jan; 53(1):40-7. PubMed ID: 18804963
[TBL] [Abstract][Full Text] [Related]
19. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice.
Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):292-300. PubMed ID: 9040461
[TBL] [Abstract][Full Text] [Related]
20. Regulation of cell-mediated immunity in cryptococcosis. II. Characterization of first-order T suppressor cells (Ts1) and induction of second-order suppressor cells.
Murphy JW; Mosley RL; Moorhead JW
J Immunol; 1983 Jun; 130(6):2876-81. PubMed ID: 6222119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
